Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baricitinib Combined With Antiviral Therapy in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study

NCT04320277 is registered in ClinicalTrials.gov with Hospital of Prato as lead sponsor.

NCT NCT04320277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04320277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baricitinib Combined With Antiviral Therapy in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study
Lead sponsor
Hospital of Prato
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 16, 2020
Completion date
July 30, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacological action